http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007500205-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007500205-A |
| titleOfInvention | Use of 2,2,3,3, tetramethylcyclopropanecarboxylic acid derivatives to treat mental disorders |
| abstract | The present invention relates to the use of 2,2,3,3 tetramethylcyclopropanecarboxylic acid derivative compounds for the preparation of a medicament for treating psychiatric disorders, preferably bipolar disorders. The invention further relates to the use of the compounds for preparing inhibitors of MIP synthase and to pharmaceutical compositions comprising the compounds for treating psychiatric disorders. Also provided are methods for treating psychiatric disorders, preferably bipolar disorders, and methods for inhibiting enzymes having MIP synthase activity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014515408-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7937110-B2 |
| priorityDate | 2003-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.